Collegium Pharmaceutical, Inc.
COLL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $69,190 | $48,155 | -$25,002 | $71,517 |
| Dep. & Amort. | $169,160 | $149,256 | $138,939 | $68,917 |
| Deferred Tax | -$26,814 | -$2,153 | -$8,391 | -$78,042 |
| Stock-Based Comp. | $32,400 | $27,136 | $22,874 | $24,255 |
| Change in WC | -$54,978 | $21,731 | -$12,713 | $13,486 |
| Other Non-Cash | $16,022 | $30,624 | $8,523 | $3,424 |
| Operating Cash Flow | $204,980 | $274,749 | $124,230 | $103,557 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,652 | -$461 | -$1,622 | -$1,944 |
| Net Acquisitions | -$267,538 | $0 | -$572,069 | $0 |
| Inv. Purchases | -$111,171 | -$92,351 | $0 | $0 |
| Inv. Sales/Matur. | $92,602 | $22,000 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$287,759 | -$70,812 | -$573,691 | -$1,944 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $7,519 | -$65,918 | $442,682 | -$50,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$60,025 | -$75,000 | -$14,063 | -$47,861 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$8,097 | $740 | $8,104 | $8,558 |
| Financing Cash Flow | -$60,603 | -$140,178 | $436,723 | -$89,303 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$143,382 | $63,759 | -$12,738 | $12,310 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $239,994 | $176,235 | $188,973 | $176,663 |
| End Cash | $96,612 | $239,994 | $176,235 | $188,973 |
| Free Cash Flow | $203,328 | $274,288 | $122,608 | $101,613 |